Diabetic with an infected foot sore?

Find out if you qualify to participate in a clinical research study that may help.

Qualified participants may receive:
  • Evaluations, exams, lab work
  • Investigational product or placebo
  • Wound care dressings
  • Compensation for time and travel
  • No-cost study related treatment

Study Snapshot

Purpose: This study is to learn whether phage, viruses designed to attack bacteria, are a safe and effective form of treatment for foot ulcers associated with foot bone infections in patients with diabetes.

Diabetes can lead to foot ulcers which can lead to serious complications.

People with diabetes often develop peripheral neuropathy, or damaged nerves, in their feet related to low blood flow. These damaged nerves and low blood flow can lead to numbness and tingling as well as sores and blisters.

When the sores are open, they're called ulcers and can become infected. The infected ulcer can lead to an infection in the foot bone and become very serious. If left untreated, a neglected ulcer can lead to amputation.

This study is to learn whether phage can effectively treat diabetic foot ulcers.

What to expect as a part of this trial:

First see if you meet three basic qualifications and you'll be directed to a clinic in your area. They will set up a time with you to finish the screening process. If you are a match and want to participate, they'll walk you through the steps for enrollment and informed consent process.

Patients choosing to participate in this study will be asked to undergo screening tests (such as blood tests, wound cultures, and bone biopsy) or procedures to find out if they are eligible.

Interested in joining this trial? Just 3 simple questions to get started:

1 Are you between
18 and 85 years old?

2 Do you have
diabetes?

3 Do you have
a foot ulcer?

Note: Other conditions not specified above may result in exclusion from the study.

If you answer yes to all three questions, you may qualify to participate in a research study that may help.

To get started, contact us!

This site is intended for U.S. residents.

See our privacy policy.

Adaptive Phage Therapeutics